Prediction of health-related quality-of-life results after lung stereotactic body radiotherapy using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CT

Abstract Background The PEGASUS trial was the first study to evaluate and demonstrate the benefits of 68Ga-perfusion PET/CT in the lung stereotactic body radiotherapy (SBRT) planning process in preserving functional lung volumes while respecting target volume coverage and doses to other organs at ri...

Descrición completa

Detalles Bibliográficos

Principais autores:	François Lucia, Jacques Lamour, Margaux Geier, Vincent Bourbonne, Fanny Pinot, Malik Nebbache, Frédérique Blanc-Béguin, Simon Hennebicq, Maëlle Mauguen, Kevin Kerleguer, Ulrike Schick, Olivier Pradier, Grégoire Le Gal, Pierre-Yves Salaun, David Bourhis, Pierre-Yves Le Roux
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-07-01
Series:	Radiation Oncology
Acceso en liña:	https://doi.org/10.1186/s13014-025-02685-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!